Condition
Heart Defect, Congenital
Total Trials
4
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Withdrawn1
Active Not Recruiting1
Unknown1
Not Yet Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT03022708Not ApplicableActive Not RecruitingPrimary
Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study
NCT07692958Not ApplicableNot Yet RecruitingPrimary
Executive Function Intervention for Children With Complex Congenital Heart Disease
NCT05066399Unknown
Fetal Cardiac Magnetic Resonance in Detection of CHD
NCT02122679Phase 4WithdrawnPrimary
Tranexamic Acid Effect on Platelet Aggregation Following Infant Cardiopulmonary Bypass
Showing all 4 trials